First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe and Critical COVID-19 Pneumonia
Zelalem Temesgen, Mariam Assi, Paschalis Vergidis, Stacey A. Rizza, Philippe R. Bauer, Brian W. Pickering, Raymund R. Razonable, Claudia R. Libertin, Charles D. Burger, Robert Orenstein, Hugo E. Vargas, Bharath Raj Varatharaj Palraj, Ala S. Dababneh, Gabrielle Chappell, Dale Chappell, Omar Ahmed, Reona Sakemura, Cameron Durrant, Saad S. Kenderian, Andrew D. Badley
doi: https://doi.org/10.1101/2020.06.08.20125369
